{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:55:35Z","timestamp":1791924935288,"version":"4.3.4"},"reference-count":108,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1124\/jpet.119.257287","type":"journal-article","created":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T01:15:21Z","timestamp":1558660521000},"page":"725-735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["CRISPR\/Cas System for Genome Editing: Progress and Prospects as a Therapeutic Tool"],"prefix":"10.1016","volume":"370","author":[{"given":"Deepak Kumar","family":"Sahel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupama","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Chitkara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.119.257287_bib1","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/j.biomaterials.2008.02.006","article-title":"Polyethyleneimine-mediated gene delivery into human adipose derived stem cells","volume":"29","author":"Ahn","year":"2008","journal-title":"Biomaterials"},{"key":"10.1124\/jpet.119.257287_bib2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1515\/bc.2011.042","article-title":"Clustered regularly interspaced short palindromic repeats (CRISPRs): the hallmark of an ingenious antiviral defense mechanism in prokaryotes","volume":"392","author":"Al-Attar","year":"2011","journal-title":"Biol Chem"},{"key":"10.1124\/jpet.119.257287_bib3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrmicro.2015.14","article-title":"CRISPR-Cas adaptation: insights into the mechanism of action","volume":"14","author":"Amitai","year":"2016","journal-title":"Nat Rev Microbiol"},{"key":"10.1124\/jpet.119.257287_bib4","doi-asserted-by":"crossref","first-page":"909.4","DOI":"10.1096\/fasebj.31.1_supplement.909.4","article-title":"Cell penetrating peptide-mediated nuclear delivery of Cas9 to enhance the utility of CRISPR\/Cas genome editing","volume":"31","author":"Axford","year":"2017","journal-title":"FASEB J"},{"key":"10.1124\/jpet.119.257287_bib5","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1126\/science.1138140","article-title":"CRISPR provides acquired resistance against viruses in prokaryotes","volume":"315","author":"Barrangou","year":"2007","journal-title":"Science"},{"key":"10.1124\/jpet.119.257287_bib6","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1042\/BJ20101021","article-title":"Effective siRNA delivery and target mRNA degradation using an amphipathic peptide to facilitate pH-dependent endosomal escape","volume":"435","author":"Bartz","year":"2011","journal-title":"Biochem J"},{"key":"10.1124\/jpet.119.257287_bib7","first-page":"309","article-title":"First-in-human phase 1 CRISPR gene editing cancer trials: are we ready?","volume":"17","author":"Baylis","year":"2017","journal-title":"Curr Gene Ther"},{"key":"10.1124\/jpet.119.257287_bib8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.omtn.2018.05.021","article-title":"Removal of HIV DNA by CRISPR from patient blood engrafts in humanized mice","volume":"12","author":"Bella","year":"2018","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1124\/jpet.119.257287_bib9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1474-4422(09)70272-8","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1124\/jpet.119.257287_bib10","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nbt.3843","article-title":"Targeting genomic rearrangements in tumor cells through Cas9-mediated insertion of a suicide gene","volume":"35","author":"Chen","year":"2017","journal-title":"Nat Biotechnol"},{"key":"10.1124\/jpet.119.257287_bib11","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nmeth.3993","article-title":"A multifunctional AAV-CRISPR-Cas9 and its host response","volume":"13","author":"Chew","year":"2016","journal-title":"Nat Methods"},{"key":"10.1124\/jpet.119.257287_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12951-019-0452-8","article-title":"Lecithin nano-liposomal particle as a CRISPR\/Cas9 complex delivery system for treating type 2 diabetes","volume":"17","author":"Cho","year":"2019","journal-title":"J Nanobiotechnology"},{"key":"10.1124\/jpet.119.257287_bib13","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1038\/ncomms4728","article-title":"Targeted genomic rearrangements using CRISPR\/Cas technology","volume":"5","author":"Choi","year":"2014","journal-title":"Nat Commun"},{"key":"10.1124\/jpet.119.257287_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12919-018-0110-4","article-title":"Gene drives in our future: challenges of and opportunities for using a self-sustaining technology in pest and vector management","volume":"12","author":"Collins","year":"2018","journal-title":"BMC Proc"},{"key":"10.1124\/jpet.119.257287_bib15","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nature.2016.20988","article-title":"CRISPR gene-editing tested in a person for the first time","volume":"539","author":"Cyranoski","year":"2016","journal-title":"Nature"},{"key":"10.1124\/jpet.119.257287_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/5584_2018_331","article-title":"CRISPR\/Cas9 for sickle cell disease: applications, future possibilities, and challenges","volume":"1144","author":"Demirci","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"10.1124\/jpet.119.257287_bib17","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev.micro.112408.134123","article-title":"CRISPR\/Cas system and its role in phage-bacteria interactions","volume":"64","author":"Deveau","year":"2010","journal-title":"Annu Rev Microbiol"},{"key":"10.1124\/jpet.119.257287_bib18","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/CIRCRESAHA.115.304351","article-title":"Permanent alteration of PCSK9 with in vivo CRISPR-Cas9 genome editing","volume":"115","author":"Ding","year":"2014","journal-title":"Circ Res"},{"key":"10.1124\/jpet.119.257287_bib19","doi-asserted-by":"crossref","first-page":"1258096","DOI":"10.1126\/science.1258096","article-title":"Genome editing. The new frontier of genome engineering with CRISPR-Cas9","volume":"346","author":"Doudna","year":"2014","journal-title":"Science"},{"key":"10.1124\/jpet.119.257287_bib20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s13059-015-0824-9","article-title":"The Cpf1 CRISPR-Cas protein expands genome-editing tools","volume":"16","author":"Fagerlund","year":"2015","journal-title":"Genome Biol"},{"key":"10.1124\/jpet.119.257287_bib21","first-page":"1615","article-title":"Cell-penetrating peptides and their utility in genome function modifications (Review)","volume":"40","author":"Gagat","year":"2017","journal-title":"Int J Mol Med"},{"key":"10.1124\/jpet.119.257287_bib22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature09523","article-title":"The CRISPR\/Cas bacterial immune system cleaves bacteriophage and plasmid DNA","volume":"468","author":"Garneau","year":"2010","journal-title":"Nature"},{"key":"10.1124\/jpet.119.257287_bib23","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s00239-005-0223-z","article-title":"The repetitive DNA elements called CRISPRs and their associated genes: evidence of horizontal transfer among prokaryotes","volume":"62","author":"Godde","year":"2006","journal-title":"J Mol Evol"},{"key":"10.1124\/jpet.119.257287_bib24","doi-asserted-by":"crossref","first-page":"22847","DOI":"10.1038\/srep22847","article-title":"Overcoming doxorubicin resistance of cancer cells by Cas9-mediated gene disruption","volume":"6","author":"Ha","year":"2016","journal-title":"Sci Rep"},{"key":"10.1124\/jpet.119.257287_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.0010060","article-title":"A guild of 45 CRISPR-associated (Cas) protein families and multiple CRISPR\/Cas subtypes exist in prokaryotic genomes","volume":"1","author":"Haft","year":"2005","journal-title":"PLOS Comput Biol"},{"key":"10.1124\/jpet.119.257287_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132260","article-title":"CRISPR\/Cas9n-mediated deletion of the snail 1Gene (SNAI1) reveals its role in regulating cell morphology, cell-cell interactions, and gene expression in ovarian cancer (RMG-1) cells","volume":"10","author":"Haraguchi","year":"2015","journal-title":"PLoS One"},{"key":"10.1124\/jpet.119.257287_bib27","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.biomaterials.2012.09.049","article-title":"Polyethyleneimine\/DNA polyplexes with reduction-sensitive hyaluronic acid derivatives shielding for targeted gene delivery","volume":"34","author":"He","year":"2013","journal-title":"Biomaterials"},{"key":"10.1124\/jpet.119.257287_bib28","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nbt.1562","article-title":"Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases","volume":"27","author":"Hockemeyer","year":"2009","journal-title":"Nat Biotechnol"},{"key":"10.1124\/jpet.119.257287_bib29","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nbt.1927","article-title":"Genetic engineering of human pluripotent cells using TALE nucleases","volume":"29","author":"Hockemeyer","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.1124\/jpet.119.257287_bib30","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature15756","article-title":"Tumour exosome integrins determine organotropic metastasis","volume":"527","author":"Hoshino","year":"2015","journal-title":"Nature"},{"key":"10.1124\/jpet.119.257287_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2016.05.001","article-title":"Genome engineering in ophthalmology: application of CRISPR\/Cas to the treatment of eye disease","volume":"53","author":"Hung","year":"2016","journal-title":"Prog Retin Eye Res"},{"key":"10.1124\/jpet.119.257287_bib32","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1146\/annurev-physiol-021115-104929","article-title":"Exosomes: fundamental biology and roles in cardiovascular physiology","volume":"78","author":"Ibrahim","year":"2016","journal-title":"Annu Rev Physiol"},{"key":"10.1124\/jpet.119.257287_bib33","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.1128\/jb.169.12.5429-5433.1987","article-title":"Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product","volume":"169","author":"Ishino","year":"1987","journal-title":"J Bacteriol"},{"key":"10.1124\/jpet.119.257287_bib34","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1146\/annurev-biophys-062215-010822","article-title":"CRISPR-Cas9 structures and mechanisms","volume":"46","author":"Jiang","year":"2017","journal-title":"Annu Rev Biophys"},{"key":"10.1124\/jpet.119.257287_bib35","doi-asserted-by":"crossref","first-page":"14500","DOI":"10.1038\/ncomms14500","article-title":"In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni","volume":"8","author":"Kim","year":"2017","journal-title":"Nat Commun"},{"key":"10.1124\/jpet.119.257287_bib36","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1101\/gr.219089.116","article-title":"Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration","volume":"27","author":"Kim","year":"2017","journal-title":"Genome Res"},{"key":"10.1124\/jpet.119.257287_bib37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jconrel.2017.09.013","article-title":"Cancer-derived exosomes as a delivery platform of CRISPR\/Cas9 confer cancer cell tropism-dependent targeting","volume":"266","author":"Kim","year":"2017","journal-title":"J Control Release"},{"key":"10.1124\/jpet.119.257287_bib38","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mib.2017.05.008","article-title":"Diversity, classification and evolution of CRISPR-Cas systems","volume":"37","author":"Koonin","year":"2017","journal-title":"Curr Opin Microbiol"},{"key":"10.1124\/jpet.119.257287_bib39","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1039\/C7SC00097A","article-title":"Synthetically controlling dendrimer flexibility improves delivery of large plasmid DNA","volume":"8","author":"Kretzmann","year":"2017","journal-title":"Chem Sci (Camb)"},{"key":"10.1124\/jpet.119.257287_bib40","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrmicro2315","article-title":"Bacteriophage resistance mechanisms","volume":"8","author":"Labrie","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"10.1124\/jpet.119.257287_bib115","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s41551-018-0252-8","article-title":"Nanoparticle delivery of CRISPR into the brain rescues a mouse model of fragile X syndrome from exaggerated repetitive behaviours","volume":"2","author":"Lee","year":"2018","journal-title":"Nat Biomed Eng"},{"key":"10.1124\/jpet.119.257287_bib41","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/s41551-017-0137-2","article-title":"Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair","volume":"1","author":"Lee","year":"2017","journal-title":"Nat Biomed Eng"},{"key":"10.1124\/jpet.119.257287_bib42","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.biomaterials.2018.04.031","article-title":"Non-viral delivery systems for CRISPR\/Cas9-based genome editing: challenges and opportunities","volume":"171","author":"Li","year":"2018","journal-title":"Biomaterials"},{"key":"10.1124\/jpet.119.257287_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/jpm8040038","article-title":"Applications of CRISPR\/Cas9 for the treatment of Duchenne muscular dystrophy","volume":"8","author":"Lim","year":"2018","journal-title":"J Pers Med"},{"key":"10.1124\/jpet.119.257287_bib44","doi-asserted-by":"crossref","first-page":"1700611","DOI":"10.1002\/advs.201700611","article-title":"Exosome\u2013liposome hybrid nanoparticles deliver CRISPR\/Cas9 system in MSCs","volume":"5","author":"Lin","year":"2018","journal-title":"Adv Sci (Weinh)"},{"key":"10.1124\/jpet.119.257287_bib45","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1080\/10717544.2018.1474964","article-title":"Delivering CRISPR: a review of the challenges and approaches","volume":"25","author":"Lino","year":"2018","journal-title":"Drug Deliv"},{"key":"10.1124\/jpet.119.257287_bib46","doi-asserted-by":"crossref","first-page":"21643","DOI":"10.1074\/jbc.M111.238485","article-title":"Structural and functional characterization of an archaeal clustered regularly interspaced short palindromic repeat (CRISPR)-associated complex for antiviral defense (CASCADE)","volume":"286","author":"Lintner","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.119.257287_bib47","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1039\/C8BM00263K","article-title":"Systemic delivery of CRISPR\/Cas9 with PEG-PLGA nanoparticles for chronic myeloid leukemia targeted therapy","volume":"6","author":"Liu","year":"2018","journal-title":"Biomater Sci"},{"key":"10.1124\/jpet.119.257287_bib48","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1126\/science.aad5725","article-title":"Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy","volume":"351","author":"Long","year":"2016","journal-title":"Science"},{"key":"10.1124\/jpet.119.257287_bib49","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00792-018-1057-0","article-title":"CRISPR RNA-guided DNA cleavage by reconstituted Type I-A immune effector complexes","volume":"23","author":"Majumdar","year":"2019","journal-title":"Extremophiles"},{"key":"10.1124\/jpet.119.257287_bib50","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nrmicro2577","article-title":"Evolution and classification of the CRISPR-Cas systems","volume":"9","author":"Makarova","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"10.1124\/jpet.119.257287_bib51","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nrmicro3569","article-title":"An updated evolutionary classification of CRISPR-Cas systems","volume":"13","author":"Makarova","year":"2015","journal-title":"Nat Rev Microbiol"},{"key":"10.1124\/jpet.119.257287_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines6040105","article-title":"CRISPR\/Cas9 for cancer therapy: hopes and challenges","volume":"6","author":"Martinez-Lage","year":"2018","journal-title":"Biomedicines"},{"key":"10.1124\/jpet.119.257287_bib54","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1021\/acschembio.7b00855","article-title":"Type II-C CRISPR-Cas9 biology, mechanism, and application","volume":"13","author":"Mir","year":"2018","journal-title":"ACS Chem Biol"},{"key":"10.1124\/jpet.119.257287_bib55","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00239-004-0046-3","article-title":"Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements","volume":"60","author":"Mojica","year":"2005","journal-title":"J Mol Evol"},{"key":"10.1124\/jpet.119.257287_bib114","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1099\/mic.0.023960-0","article-title":"Short motif sequences determine the targets of the prokaryotic CRISPR defence system","volume":"155","author":"Mojica","year":"2009","journal-title":"Microbiology"},{"key":"10.1124\/jpet.119.257287_bib56","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1021\/acs.bioconjchem.7b00057","article-title":"In vivo delivery of CRISPR\/Cas9 for therapeutic gene editing: progress and challenges","volume":"28","author":"Mout","year":"2017","journal-title":"Bioconjug Chem"},{"key":"10.1124\/jpet.119.257287_bib57","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/2277-9175.98152","article-title":"Viral and nonviral delivery systems for gene delivery","volume":"1","author":"Nayerossadat","year":"2012","journal-title":"Adv Biomed Res"},{"key":"10.1124\/jpet.119.257287_bib58","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.aad5143","article-title":"In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy","volume":"351","author":"Nelson","year":"2016","journal-title":"Science"},{"key":"10.1124\/jpet.119.257287_bib59","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.cell.2014.01.027","article-title":"Generation of gene-modified cynomolgus monkey via Cas9\/RNA-mediated gene targeting in one-cell embryos","volume":"156","author":"Niu","year":"2014","journal-title":"Cell"},{"key":"10.1124\/jpet.119.257287_bib60","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nsmb.2820","article-title":"Cas1\u2013Cas2 complex formation mediates spacer acquisition during CRISPR\u2013Cas adaptive immunity","volume":"21","author":"Nu\u00f1ez","year":"2014","journal-title":"Nat Struct Mol Biol"},{"key":"10.1124\/jpet.119.257287_bib61","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1182\/blood.V128.22.4703.4703","article-title":"Therapeutic Crispr\/Cas9 genome editing for treating sickle cell disease","volume":"128","author":"Park","year":"2016","journal-title":"Blood"},{"key":"10.1124\/jpet.119.257287_bib62","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nnano.2007.387","article-title":"Nanocarriers as an emerging platform for cancer therapy","volume":"2","author":"Peer","year":"2007","journal-title":"Nat Nanotechnol"},{"key":"10.1124\/jpet.119.257287_bib63","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.cell.2014.09.014","article-title":"CRISPR-Cas9 knockin mice for genome editing and cancer modeling","volume":"159","author":"Platt","year":"2014","journal-title":"Cell"},{"key":"10.1124\/jpet.119.257287_bib64","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1111\/j.1365-2958.2010.07265.x","article-title":"Transcription, processing and function of CRISPR cassettes in Escherichia coli","volume":"77","author":"Pougach","year":"2010","journal-title":"Mol Microbiol"},{"key":"10.1124\/jpet.119.257287_bib65","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1101\/gr.171264.113","article-title":"Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA","volume":"24","author":"Ramakrishna","year":"2014","journal-title":"Genome Res"},{"key":"10.1124\/jpet.119.257287_bib66","first-page":"GE01","article-title":"Non viral vectors in gene therapy\u2014an overview","volume":"9","author":"Ramamoorth","year":"2015","journal-title":"J Clin Diagn Res"},{"key":"10.1124\/jpet.119.257287_bib67","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/nmeth0508-374","article-title":"Unexpected failure rates for modular assembly of engineered zinc fingers","volume":"5","author":"Ramirez","year":"2008","journal-title":"Nat Methods"},{"key":"10.1124\/jpet.119.257287_bib69","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat Protoc"},{"key":"10.1124\/jpet.119.257287_bib70","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.biochi.2015.03.025","article-title":"The CRISPR-Cas immune system: biology, mechanisms and applications","volume":"117","author":"Rath","year":"2015","journal-title":"Biochimie"},{"key":"10.1124\/jpet.119.257287_bib71","doi-asserted-by":"crossref","first-page":"439","DOI":"10.4172\/2161-0460.1000439","article-title":"The potential of CRISPR\/Cas9 gene editing as a treatment strategy for Alzheimer\u2019s disease","volume":"8","author":"Rohn","year":"2018","journal-title":"J Alzheimers Dis Parkinsonism"},{"key":"10.1124\/jpet.119.257287_bib72","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nbt.3836","article-title":"In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis","volume":"35","author":"Roper","year":"2017","journal-title":"Nat Biotechnol"},{"key":"10.1124\/jpet.119.257287_bib73","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1093\/bioinformatics\/btp586","article-title":"CRISPI: a CRISPR interactive database","volume":"25","author":"Rousseau","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1124\/jpet.119.257287_bib74","doi-asserted-by":"crossref","first-page":"7147","DOI":"10.1039\/c2cs35094g","article-title":"Cationic polymers and their therapeutic potential","volume":"41","author":"Samal","year":"2012","journal-title":"Chem Soc Rev"},{"key":"10.1124\/jpet.119.257287_bib76","doi-asserted-by":"crossref","first-page":"17291","DOI":"10.1074\/jbc.RA118.004554","article-title":"CRISPR-delivery particles targeting nuclear receptor-interacting protein 1 (Nrip1) in adipose cells to enhance energy expenditure","volume":"293","author":"Shen","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.119.257287_bib77","doi-asserted-by":"crossref","first-page":"E1243","DOI":"10.1073\/pnas.1621174114","article-title":"Endothelium-targeted overexpression of heat shock protein 27 ameliorates blood-brain barrier disruption after ischemic brain injury","volume":"114","author":"Shi","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.119.257287_bib78","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrmicro.2016.184","article-title":"Diversity and evolution of class 2 CRISPR-Cas systems","volume":"15","author":"Shmakov","year":"2017","journal-title":"Nat Rev Microbiol"},{"key":"10.1124\/jpet.119.257287_bib79","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.molcel.2016.03.002","article-title":"Rewiring Cas9 to target new PAM sequences","volume":"61","author":"Siksnys","year":"2016","journal-title":"Mol Cell"},{"key":"10.1124\/jpet.119.257287_bib81","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/317230a0","article-title":"Insertion of DNA sequences into the human chromosomal \u03b2-globin locus by homologous recombination","volume":"317","author":"Smithies","year":"1985","journal-title":"Nature"},{"key":"10.1124\/jpet.119.257287_bib83","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1196\/annals.1359.012","article-title":"Endo-Porter: a novel reagent for safe, effective delivery of substances into cells","volume":"1058","author":"Summerton","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/jpet.119.257287_bib84","doi-asserted-by":"crossref","first-page":"10342","DOI":"10.1038\/srep10342","article-title":"Targeted mutagenesis in soybean using the CRISPR-Cas9 system","volume":"5","author":"Sun","year":"2015","journal-title":"Sci Rep"},{"key":"10.1124\/jpet.119.257287_bib116","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/978-1-4939-6518-2_7","article-title":"Cell-Penetrating Peptide-Mediated Delivery of Cas9 Protein and Guide RNA for Genome Editing","volume":"1507","author":"Suresh","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1124\/jpet.119.257287_bib85","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153689","article-title":"Genome-wide CRISPR-Cas9 screen identifies MicroRNAs that regulate myeloid leukemia cell growth","volume":"11","author":"Wallace","year":"2016","journal-title":"PLoS One"},{"key":"10.1124\/jpet.119.257287_bib86","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1089\/104303404322959551","article-title":"Comparison of adenoviral and adeno-associated viral vectors for pancreatic gene delivery in vivo","volume":"15","author":"Wang","year":"2004","journal-title":"Hum Gene Ther"},{"key":"10.1124\/jpet.119.257287_bib87","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.1073\/pnas.1712963115","article-title":"Nonviral gene editing via CRISPR\/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide","volume":"115","author":"Wang","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.119.257287_bib88","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1073\/pnas.1520244113","article-title":"Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles","volume":"113","author":"Wang","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.119.257287_bib89","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.tibtech.2016.12.009","article-title":"Will nanotechnology bring new hope for gene delivery?","volume":"35","author":"Wong","year":"2017","journal-title":"Trends Biotechnol"},{"key":"10.1124\/jpet.119.257287_bib90","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1002\/jcp.24991","article-title":"The SWI\/SNF ATPases are required for triple negative breast cancer cell proliferation","volume":"230","author":"Wu","year":"2015","journal-title":"J Cell Physiol"},{"key":"10.1124\/jpet.119.257287_bib92","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/mt.2009.255","article-title":"Effect of genome size on AAV vector packaging","volume":"18","author":"Wu","year":"2010","journal-title":"Mol Ther"},{"key":"10.1124\/jpet.119.257287_bib94","doi-asserted-by":"crossref","first-page":"6901","DOI":"10.1007\/s13277-014-1925-x","article-title":"Urothelial carcinoma associated 1 is a hypoxia-inducible factor-1\u03b1-targeted long noncoding RNA that enhances hypoxic bladder cancer cell proliferation, migration, and invasion","volume":"35","author":"Xue","year":"2014","journal-title":"Tumour Biol"},{"key":"10.1124\/jpet.119.257287_bib95","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nature13589","article-title":"CRISPR-mediated direct mutation of cancer genes in the mouse liver","volume":"514","author":"Xue","year":"2014","journal-title":"Nature"},{"key":"10.1124\/jpet.119.257287_bib96","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1039\/C1NR11188D","article-title":"Gold nanoparticles: preparation, properties, and applications in bionanotechnology","volume":"4","author":"Yeh","year":"2012","journal-title":"Nanoscale"},{"key":"10.1124\/jpet.119.257287_bib97","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41571-019-0166-8","article-title":"CRISPR-Cas: a tool for cancer research and therapeutics","volume":"16","author":"Yin","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1124\/jpet.119.257287_bib98","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nbt.2884","article-title":"Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype","volume":"32","author":"Yin","year":"2014","journal-title":"Nat Biotechnol"},{"key":"10.1124\/jpet.119.257287_bib99","doi-asserted-by":"crossref","first-page":"20881","DOI":"10.18632\/oncotarget.14930","article-title":"microRNA-210-3p depletion by CRISPR\/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma","volume":"8","author":"Yoshino","year":"2017","journal-title":"Oncotarget"},{"key":"10.1124\/jpet.119.257287_bib100","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.stem.2016.01.021","article-title":"A single CRISPR-Cas9 deletion strategy that targets the majority of DMD patients restores dystrophin function in hiPSC-derived muscle cells","volume":"18","author":"Young","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1124\/jpet.119.257287_bib102","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.semcancer.2018.04.001","article-title":"CRISPR\/Cas9 for cancer research and therapy","volume":"55","author":"Zhan","year":"2019","journal-title":"Semin Cancer Biol"},{"key":"10.1124\/jpet.119.257287_bib103","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1021\/acs.molpharmaceut.8b00434","article-title":"PEGylated chitosan for nonviral aerosol and mucosal delivery of the CRISPR\/Cas9 system in vitro","volume":"15","author":"Zhang","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1124\/jpet.119.257287_bib104","doi-asserted-by":"crossref","DOI":"10.1038\/am.2017.185","article-title":"Lipid nanoparticle-mediated efficient delivery of CRISPR\/Cas9 for tumor therapy","volume":"9","author":"Zhang","year":"2017","journal-title":"NPG Asia Mater"},{"key":"10.1124\/jpet.119.257287_bib105","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1602814","article-title":"CRISPR-Cpf1 correction of muscular dystrophy mutations in human cardiomyocytes and mice","volume":"3","author":"Zhang","year":"2017","journal-title":"Sci Adv"},{"key":"10.1124\/jpet.119.257287_bib106","doi-asserted-by":"crossref","DOI":"10.1002\/marc.201800068","article-title":"Cationic polymer-mediated CRISPR\/Cas9 plasmid delivery for genome editing","volume":"40","author":"Zhang","year":"2019","journal-title":"Macromol Rapid Commun"},{"key":"10.1124\/jpet.119.257287_bib107","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/gt.2015.2","article-title":"Harnessing the clustered regularly interspaced short palindromic repeat (CRISPR)\/CRISPR-associated Cas9 system to disrupt the hepatitis B virus","volume":"22","author":"Zhen","year":"2015","journal-title":"Gene Ther"},{"key":"10.1124\/jpet.119.257287_bib108","doi-asserted-by":"crossref","first-page":"9634","DOI":"10.18632\/oncotarget.14176","article-title":"Inhibition of long non-coding RNA UCA1 by CRISPR\/Cas9 attenuated malignant phenotypes of bladder cancer","volume":"8","author":"Zhen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1124\/jpet.119.257287_bib109","doi-asserted-by":"crossref","first-page":"9375","DOI":"10.18632\/oncotarget.14072","article-title":"Targeted delivery of CRISPR\/Cas9 to prostate cancer by modified gRNA using a flexible aptamer-cationic liposome","volume":"8","author":"Zhen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1124\/jpet.119.257287_bib110","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12977-015-0150-z","article-title":"The CRISPR\/Cas9 system inactivates latent HIV-1 proviral DNA","volume":"12","author":"Zhu","year":"2015","journal-title":"Retrovirology"},{"key":"10.1124\/jpet.119.257287_bib111","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol Ther"},{"key":"10.1124\/jpet.119.257287_bib112","doi-asserted-by":"crossref","first-page":"7391","DOI":"10.1038\/ncomms8391","article-title":"Somatic CRISPR\/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling","volume":"6","author":"Zuckermann","year":"2015","journal-title":"Nat Commun"},{"key":"10.1124\/jpet.119.257287_bib113","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nbt.3081","article-title":"Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo","volume":"33","author":"Zuris","year":"2015","journal-title":"Nat Biotechnol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524260444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524260444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.119.257287","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T19:53:57Z","timestamp":1739994837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524260444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":108,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0022356524260444"],"URL":"https:\/\/doi.org\/10.1124\/jpet.119.257287","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CRISPR\/Cas System for Genome Editing: Progress and Prospects as a Therapeutic Tool","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.119.257287","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}